How Sun Pharma’s U.S. buy could spur other Indian pharma firms' global expansion

Name: How Sun Pharma’s U.S. buy could spur other Indian pharma firms' global expansion
Uploaded: 2026-04-28T07:45:35.000Z
Duration: 5 min 13 s
Description: Kunal Dhamesha, Senior Analyst at Macquarie Capital, says Sun Pharma’s U.S. acquisition could encourage its peers to look beyond generics and pursue M&As in specialty and patented medicines, though appetite will vary by company strategy, R&D depth and risk tolerance.

Kunal Dhamesha, Senior Analyst at Macquarie Capital, says Sun Pharma’s U.S. acquisition could encourage its peers to look beyond generics and pursue M&As in specialty and patented medicines, though appetite will vary by company strategy, R&D depth and risk tolerance.

05:13

Tue, Apr 28 20263:45 AM EDT